Literature DB >> 22563818

CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?

Varsha Gandhi1, Kumudha Balakrishnan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22563818      PMCID： PMC4123321          DOI： 10.3109/10428194.2012.688966

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  11 in total

1.  CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.

Authors:  Melinda Burgess; Catherine Cheung; Lynne Chambers; Karunya Ravindranath; Gunjeet Minhas; Louise Knop; Peter Mollee; Nigel A J McMillan; Devinder Gill
Journal:  Leuk Lymphoma       Date:  2012-04-19

Review 2.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

3.  High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.

Authors:  Jan A Burger; Maite P Quiroga; Elena Hartmann; Andrea Bürkle; William G Wierda; Michael J Keating; Andreas Rosenwald
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

Review 4.  Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.

Authors:  Iskra Pusic; John F DiPersio
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

5.  Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.

Authors:  Angela Schulz; Grischa Toedt; Thorsten Zenz; Stephan Stilgenbauer; Peter Lichter; Martina Seiffert
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

6.  Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia.

Authors:  G Mazur; T Wróbel; A Butrym; K Kapelko-Słowik; R Poreba; K Kuliczkowski
Journal:  Neoplasma       Date:  2007       Impact factor: 2.575

7.  Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.

Authors:  Antje Lebrecht; Christoph Grimm; Tilmann Lantzsch; Elisabeth Ludwig; Lukas Hefler; Eva Ulbrich; Heinz Koelbl
Journal:  Tumour Biol       Date:  2004 Jan-Apr

8.  Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.

Authors:  Antonina V Kurtova; Kumudha Balakrishnan; Rong Chen; Wei Ding; Susanne Schnabl; Maite P Quiroga; Mariela Sivina; William G Wierda; Zeev Estrov; Michael J Keating; Medhat Shehata; Ulrich Jäger; Varsha Gandhi; Neil E Kay; William Plunkett; Jan A Burger
Journal:  Blood       Date:  2009-09-17       Impact factor: 22.113

9.  CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.

Authors:  Hernan Roca; Zachary Varsos; Kenneth J Pienta
Journal:  J Biol Chem       Date:  2008-07-08       Impact factor: 5.157

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582
View more
  1 in total

1.  Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC.

Authors:  Xiaofei Song; Zie Wang; Yan Jin; Yong Wang; Wenbing Duan
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.